NDT Advance Access originally published online on August 18, 2006
Nephrology Dialysis Transplantation 2007 22(1):290-291; doi:10.1093/ndt/gfl499
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Decreased serum fetuin-A levels after a single haemodialysis session
Email: mariocozzolino@hotmail.com
| The first 10% of the full text of this article appears below. |
Sir,
Cardiovascular disease (CVD) is the leading cause of mortality in haemodialysis (HD) [1]. Elevated incidence of vascular calcification (VC) is observed in HD. Fetuin-A
1Renal Division
S. Paolo Hospital
University of Milan
Milan
Italy
2Chair of Internal Medicine
University of Ferrara
Ferrara
Italy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. C. Shroff, V. Shah, M. P. Hiorns, M. Schoppet, L. C. Hofbauer, G. Hawa, L. J. Schurgers, A. Singhal, I. Merryweather, P. Brogan, et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3263 - 3271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marino and N. Giotta Cinacalcet, fetuin-A and interleukin-6 Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1460 - 1461. [Full Text] [PDF] |
||||
